Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 26;22:491–517. doi: 10.1016/j.bioactmat.2022.10.016

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 6 — Fusion of bacterial outer membranes/tumor cell membrane-based nanovaccines for immunotherapy. (A) The fabrication of eukaryotic-prokaryotic vesicle-coated PI@EPV nanovaccines. (B) Fusion membrane vesicle endocytosis by DC2.4 murine dendritic cells (C) Tumor growth curves in a melanoma breast cancer model after immunization with the nanovaccine. (D) Percentage of tumor-free mice after tumor challenge. (E–F) The proportions of splenic lymphocytes expressing different T cells after immunization. Copyright © 2020, WILEY–VCH Verlag GmbH & Co. KGaA, Weinheim [125].